| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.831 | 0.003 | 0.831 | Vasodilator, coronary | 0.335 0.063 DBMET00536 | ||
| 0.795 | 0.004 | 0.795 | Spasmolytic | 0.179 0.137 DBMET00536 | ||
| 0.78 | 0.004 | 0.78 | Vasodilator, peripheral | 0.388 0.059 DBMET00536 | ||
| 0.775 | 0.004 | 0.775 | Antiadrenergic | |||
| 0.774 | 0.004 | 0.774 | Adrenaline antagonist | |||
| 0.762 | 0.001 | 0.762 | Beta adrenoreceptor antagonist | 0.073 0.034 DBMET00536 | ||
| 0.686 | 0.001 | 0.686 | Beta 1 adrenoreceptor antagonist | 0.069 0.027 DBMET00536 | ||
| 0.686 | 0.005 | 0.686 | Cardiotonic | |||
| 0.685 | 0.008 | 0.685 | 5 Hydroxytryptamine release stimulant | 0.61 0.014 DBMET00536 | ||
| 0.637 | 0.003 | 0.637 | Anesthetic local | 0.112 0.073 DBMET00536 | ||
| 0.63 | 0.015 | 0.63 | Cholesterol antagonist | 0.444 0.042 DBMET00536 | ||
| 0.626 | 0.014 | 0.626 | Antithrombotic | 0.278 0.105 DBMET00536 | ||
| 0.6 | 0.001 | 0.6 | Beta 2 adrenoreceptor antagonist | 0.055 0.029 DBMET00536 | ||
| 0.56 | 0.003 | 0.56 | Insulin sensitizer | 0.209 0.065 DBMET00536 | ||
| 0.534 | 0.009 | 0.534 | Psychostimulant | 0.192 0.084 DBMET00536 | ||
| 0.558 | 0.036 | 0.558 | Cyclophilin D inhibitor | |||
| 0.526 | 0.01 | 0.526 | Vasodilator | |||
| 0.529 | 0.024 | 0.55 | 5 Hydroxytryptamine release inhibitor | 0.55 0.019 DBMET00536 | DBMET00536 | |
| 0.457 | 0.011 | 0.457 | P-glycoprotein inhibitor | |||
| 0.472 | 0.04 | 0.472 | Histamine release inhibitor | 0.465 0.043 DBMET00536 | ||
| 0.439 | 0.009 | 0.439 | Sodium/bile acid cotransporter inhibitor | 0.315 0.066 DBMET00536 | ||
| 0.439 | 0.022 | 0.439 | Hypoglycemic | |||
| 0.465 | 0.05 | 0.465 | Transcription factor NF kappa B inhibitor | 0.262 0.119 DBMET00536 | ||
| 0.415 | 0.003 | 0.415 | Adrenaline agonist | 0.077 0.062 DBMET00536 | ||
| 0.425 | 0.013 | 0.425 | Cyclic AMP phosphodiesterase inhibitor | 0.261 0.058 DBMET00536 | ||
| 0.417 | 0.01 | 0.417 | DNA methylase inhibitor | 0.217 0.068 DBMET00536 | ||
| 0.475 | 0.071 | 0.555 | Caspase 9 stimulant | 0.555 0.044 DBMET00536 | DBMET00536 | |
| 0.396 | 0.009 | 0.396 | DNA methyltransferase I inhibitor | 0.221 0.059 DBMET00536 | ||
| 0.438 | 0.053 | 0.438 | Antiobesity | |||
| 0.377 | 0.002 | 0.377 | Beta 3 adrenoreceptor antagonist | 0.077 0.026 DBMET00536 | ||
| 0.424 | 0.066 | 0.522 | Calcium channel L-type activator | 0.522 0.02 DBMET00536 | DBMET00536 | |
| 0.4 | 0.05 | 0.4 | Immunostimulant | 0.23 0.105 DBMET00536 | ||
| 0.35 | 0.01 | 0.35 | Gastrin inhibitor | 0.293 0.038 DBMET00536 | ||
| 0.371 | 0.033 | 0.371 | Platelet antagonist | |||
| 0.325 | 0.01 | 0.325 | Insulin secretagoues | |||
| 0.345 | 0.037 | 0.345 | Hypolipemic | |||
| 0.312 | 0.004 | 0.312 | Calcium antagonist | 0.121 0.035 DBMET00536 | ||
| 0.374 | 0.074 | 0.374 | Immunosuppressant | |||
| 0.301 | 0.002 | 0.301 | Beta adrenoreceptor agonist | 0.043 0.042 DBMET00536 | ||
| 0.288 | 0.015 | 0.288 | Phospholipase A2 inhibitor | 0.138 0.088 DBMET00536 | ||
| 0.299 | 0.034 | 0.431 | Tyrosine 3 hydroxylase inhibitor | 0.431 0.005 DBMET00536 | DBMET00536 | |
| 0.323 | 0.061 | 0.898 | Aldehyde oxidase inhibitor | 0.898 0.003 DBMET00536 | DBMET00536 | |
| 0.314 | 0.052 | 0.314 | DNA damaging | 0.198 0.117 DBMET00536 | ||
| 0.301 | 0.053 | 0.301 | Transcription factor STAT3 inhibitor | 0.21 0.121 DBMET00536 | ||
| 0.247 | 0.002 | 0.247 | Beta 3 adrenoreceptor agonist | |||
| 0.248 | 0.004 | 0.248 | Adenylate cyclase stimulant | 0.207 0.011 DBMET00536 | ||
| 0.252 | 0.009 | 0.252 | Toll-Like receptor 2 antagonist | 0.194 0.026 DBMET00536 | ||
| 0.258 | 0.015 | 0.258 | Calcium channel blocker | |||
| 0.262 | 0.021 | 0.262 | Interleukin 6 antagonist | |||
| 0.264 | 0.029 | 0.264 | Diuretic | 0.118 0.107 DBMET00536 | ||
| 0.248 | 0.014 | 0.248 | Nav1.3 sodium channel blocker | |||
| 0.289 | 0.066 | 0.321 | Insulysin inhibitor | 0.321 0.047 DBMET00536 | DBMET00536 | |
| 0.278 | 0.058 | 0.45 | 5 Hydroxytryptamine uptake stimulant | 0.45 0.007 DBMET00536 | DBMET00536 | |
| 0.301 | 0.085 | 0.301 | Apoptosis antagonist | |||
| 0.215 | 0.003 | 0.215 | Sphingosine 1-phosphate receptor agonist | 0.04 0.037 DBMET00536 | ||
| 0.252 | 0.049 | 0.357 | Anesthetic general | 0.357 0.023 DBMET00536 | DBMET00536 | |
| 0.209 | 0.014 | 0.329 | Catalase inhibitor | 0.329 0.005 DBMET00536 | DBMET00536 | |
| 0.177 | 0.006 | 0.177 | Ornithine decarboxylase inhibitor | 0.121 0.025 DBMET00536 | ||
| 0.19 | 0.02 | 0.19 | Bronchodilator | |||
| 0.186 | 0.017 | 0.191 | Mucolytic | 0.191 0.015 DBMET00536 | DBMET00536 | |
| 0.2 | 0.034 | 0.7 | Alpha-N-acetylglucosaminidase inhibitor | 0.7 0.003 DBMET00536 | DBMET00536 | |
| 0.168 | 0.003 | 0.168 | Sphingosine 1-phosphate receptor 1 agonist | 0.038 0.035 DBMET00536 | ||
| 0.179 | 0.016 | 0.179 | Gastric antisecretory | 0.086 0.084 DBMET00536 | ||
| 0.169 | 0.013 | 0.169 | Toll-Like receptor 4 antagonist | 0.103 0.065 DBMET00536 | ||
| 0.222 | 0.066 | 0.222 | Platelet aggregation inhibitor | |||
| 0.178 | 0.026 | 0.18 | Expectorant | 0.18 0.025 DBMET00536 | DBMET00536 | |
| 0.238 | 0.088 | 0.316 | Interleukin agonist | 0.316 0.041 DBMET00536 | DBMET00536 | |
| 0.196 | 0.047 | 0.23 | Phospholipase C inhibitor | 0.23 0.03 DBMET00536 | DBMET00536 | |
| 0.187 | 0.039 | 0.187 | Nav1.2 sodium channel blocker | |||
| 0.191 | 0.045 | 0.21 | Protein kinase stimulant | 0.21 0.038 DBMET00536 | DBMET00536 | |
| 0.152 | 0.009 | 0.164 | Glutamate release inhibitor | 0.164 0.007 DBMET00536 | DBMET00536 | |
| 0.236 | 0.097 | 0.236 | Transcription factor STAT inhibitor | 0.199 0.14 DBMET00536 | ||
| 0.164 | 0.028 | 0.164 | Nav1.1 sodium channel blocker | |||
| 0.138 | 0.004 | 0.138 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.194 | 0.061 | 0.194 | Growth hormone agonist | |||
| 0.172 | 0.039 | 0.172 | DNA polymerase I inhibitor | |||
| 0.211 | 0.078 | 0.211 | Interleukin antagonist | |||
| 0.168 | 0.037 | 0.168 | Proteasome inhibitor | 0.102 0.084 DBMET00536 | ||
| 0.17 | 0.039 | 0.17 | Neuropeptide Y1 antagonist | 0.134 0.092 DBMET00536 | ||
| 0.157 | 0.026 | 0.157 | Mediator release inhibitor | |||
| 0.167 | 0.037 | 0.167 | Interleukin 4 antagonist | |||
| 0.135 | 0.005 | 0.135 | Estrogen-related receptor beta agonist | 0.131 0.006 DBMET00536 | ||
| 0.156 | 0.028 | 0.191 | Photosensitizer | 0.191 0.015 DBMET00536 | DBMET00536 | |
| 0.128 | 0.003 | 0.128 | Beta 2 adrenoreceptor agonist | 0.065 0.032 DBMET00536 | ||
| 0.127 | 0.003 | 0.127 | Calcium-sensing receptor antagonist | |||
| 0.135 | 0.013 | 0.135 | Calcium channel L-type blocker | |||
| 0.182 | 0.061 | 0.182 | Thrombolytic | |||
| 0.123 | 0.002 | 0.123 | Beta 1 adrenoreceptor agonist | |||
| 0.146 | 0.026 | 0.16 | Sphingomyelinase inhibitor | 0.16 0.02 DBMET00536 | DBMET00536 | |
| 0.203 | 0.085 | 0.308 | Nitric-oxide synthase stimulant | 0.308 0.01 DBMET00536 | DBMET00536 | |
| 0.205 | 0.092 | 0.231 | Peptidyltransferase inhibitor | 0.231 0.066 DBMET00536 | DBMET00536 | |
| 0.155 | 0.042 | 0.184 | Cholesterol synthesis inhibitor | 0.184 0.031 DBMET00536 | DBMET00536 | |
| 0.216 | 0.104 | 0.216 | Antioxidant | |||
| 0.214 | 0.103 | 0.34 | DNA synthesis inhibitor | 0.34 0.032 DBMET00536 | DBMET00536 | |
| 0.149 | 0.039 | 0.157 | Vanilloid 1 agonist | 0.157 0.032 DBMET00536 | DBMET00536 | |
| 0.145 | 0.038 | 0.155 | Sphingosine 1-phosphate receptor 4 antagonist | 0.155 0.029 DBMET00536 | DBMET00536 | |
| 0.123 | 0.018 | 0.15 | Aminopeptidase I inhibitor | 0.15 0.012 DBMET00536 | DBMET00536 | |
| 0.198 | 0.096 | 0.198 | Angiogenesis stimulant | 0.137 0.131 DBMET00536 | ||
| 0.15 | 0.048 | 0.173 | Cyclooxygenase 3 inhibitor | 0.173 0.032 DBMET00536 | DBMET00536 | |
| 0.141 | 0.042 | 0.194 | Aminopeptidase B inhibitor | 0.194 0.023 DBMET00536 | DBMET00536 | |
| 0.234 | 0.137 | 0.251 | Interleukin 2 agonist | 0.251 0.117 DBMET00536 | DBMET00536 | |
| 0.134 | 0.038 | 0.134 | Protease inhibitor | |||
| 0.135 | 0.041 | 0.135 | Caspase 3 inhibitor | 0.126 0.052 DBMET00536 | ||
| 0.161 | 0.068 | 0.204 | Melanin inhibitor | 0.204 0.039 DBMET00536 | DBMET00536 | |
| 0.096 | 0.005 | 0.096 | Plasmepsin II inhibitor | 0.039 0.034 DBMET00536 | ||
| 0.125 | 0.034 | 0.125 | Factor V inhibitor | |||
| 0.174 | 0.086 | 0.174 | Platelet adhesion inhibitor | |||
| 0.099 | 0.011 | 0.099 | Thromboxane antagonist | |||
| 0.107 | 0.019 | 0.107 | Leukotriene antagonist | |||
| 0.157 | 0.07 | 0.244 | Interferon gamma antagonist | 0.244 0.029 DBMET00536 | DBMET00536 | |
| 0.123 | 0.036 | 0.123 | Folate antagonist | |||
| 0.107 | 0.023 | 0.194 | Phenylalanine 4-hydroxylase inhibitor | 0.194 0.007 DBMET00536 | DBMET00536 | |
| 0.091 | 0.01 | 0.091 | Thromboxane A2 antagonist | |||
| 0.09 | 0.009 | 0.09 | Epithelial sodium channel blocker | 0.061 0.028 DBMET00536 | ||
| 0.135 | 0.055 | 0.141 | Alkylator | 0.141 0.052 DBMET00536 | DBMET00536 | |
| 0.195 | 0.118 | 0.195 | Calpain inhibitor | 0.183 0.131 DBMET00536 | ||
| 0.095 | 0.02 | 0.095 | Cathepsin D inhibitor | |||
| 0.16 | 0.086 | 0.211 | ATPase inhibitor | 0.211 0.029 DBMET00536 | DBMET00536 | |
| 0.125 | 0.051 | 0.125 | Calcium channel (voltage-sensitive) blocker | |||
| 0.144 | 0.072 | 0.144 | Lipid peroxidase inhibitor | |||
| 0.085 | 0.014 | 0.085 | Leukotriene B4 antagonist | 0.051 0.042 DBMET00536 | ||
| 0.112 | 0.041 | 0.13 | Alcohol dehydrogenase inhibitor | 0.13 0.028 DBMET00536 | DBMET00536 | |
| 0.104 | 0.034 | 0.104 | Glutathione S-transferase inhibitor | 0.101 0.036 DBMET00536 | ||
| 0.1 | 0.03 | 0.164 | Keratolytic | 0.164 0.012 DBMET00536 | DBMET00536 | |
| 0.131 | 0.061 | 0.388 | Aldehyde dehydrogenase inhibitor | 0.388 0.006 DBMET00536 | DBMET00536 | |
| 0.078 | 0.01 | 0.078 | Lysophosphatidic acid 3 receptor antagonist | 0.078 0.01 DBMET00536 | ||
| 0.137 | 0.07 | 0.137 | Bone formation stimulant | |||
| 0.096 | 0.03 | 0.096 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.097 | 0.031 | 0.111 | Interferon agonist | 0.111 0.021 DBMET00536 | DBMET00536 | |
| 0.192 | 0.126 | 0.491 | Superoxide dismutase inhibitor | 0.491 0.014 DBMET00536 | DBMET00536 | |
| 0.152 | 0.086 | 0.229 | Arachidonic acid antagonist | 0.229 0.012 DBMET00536 | DBMET00536 | |
| 0.082 | 0.017 | 0.082 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.099 | 0.035 | 0.099 | Somatostatin 1 agonist | |||
| 0.113 | 0.05 | 0.176 | Carbonic anhydrase III inhibitor | 0.176 0.021 DBMET00536 | DBMET00536 | |
| 0.083 | 0.02 | 0.083 | Prostaglandin F2 alpha antagonist | |||
| 0.087 | 0.025 | 0.087 | Peroxisome proliferator-activated receptor gamma antagonist | 0.07 0.053 DBMET00536 | ||
| 0.098 | 0.037 | 0.16 | Granulocyte macrophage colony stimulating factor agonist | 0.16 0.004 DBMET00536 | DBMET00536 | |
| 0.108 | 0.047 | 0.112 | Interleukin 1 beta converting enzyme inhibitor | 0.112 0.043 DBMET00536 | DBMET00536 | |
| 0.183 | 0.124 | 0.183 | Tumour necrosis factor alpha release inhibitor | |||
| 0.133 | 0.076 | 0.143 | Nav1.6 sodium channel blocker | 0.143 0.062 DBMET00536 | DBMET00536 | |
| 0.175 | 0.118 | 0.175 | Antiamyloidogenic | |||
| 0.091 | 0.036 | 0.295 | Histidine decarboxylase inhibitor | 0.295 0.006 DBMET00536 | DBMET00536 | |
| 0.08 | 0.027 | 0.08 | Prostaglandin EP2 antagonist | |||
| 0.07 | 0.018 | 0.07 | 5 Hydroxytryptamine 1B agonist | |||
| 0.083 | 0.033 | 0.083 | Phosphodiesterase III inhibitor | |||
| 0.076 | 0.026 | 0.076 | Nitric oxide donor | |||
| 0.088 | 0.039 | 0.088 | Cathepsin G inhibitor | 0.085 0.04 DBMET00536 | ||
| 0.053 | 0.004 | 0.053 | Lysophosphatidic acid receptor 1 agonist | 0.045 0.004 DBMET00536 | ||
| 0.055 | 0.006 | 0.055 | Plasmepsin I inhibitor | |||
| 0.171 | 0.123 | 0.171 | Free radical scavenger | |||
| 0.095 | 0.05 | 0.095 | NMDA receptor antagonist | |||
| 0.049 | 0.004 | 0.049 | Prostaglandin F2 alpha agonist | 0.032 0.008 DBMET00536 | ||
| 0.109 | 0.064 | 0.109 | Electron transport complex I inhibitor | 0.106 0.07 DBMET00536 | ||
| 0.056 | 0.013 | 0.056 | Squalene synthetase inhibitor | |||
| 0.052 | 0.009 | 0.052 | Prostaglandin agonist | 0.03 0.023 DBMET00536 | ||
| 0.093 | 0.051 | 0.093 | ATPase (Vacuolar H+) inhibitor | 0.092 0.052 DBMET00536 | ||
| 0.068 | 0.027 | 0.068 | Sphingosine 1-phosphate receptor 3 antagonist | 0.06 0.038 DBMET00536 | ||
| 0.072 | 0.032 | 0.093 | Interferon inducer | 0.093 0.016 DBMET00536 | DBMET00536 | |
| 0.113 | 0.073 | 0.139 | Adenylate cyclase inhibitor | 0.139 0.053 DBMET00536 | DBMET00536 | |
| 0.097 | 0.057 | 0.314 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.314 0.005 DBMET00536 | DBMET00536 | |
| 0.063 | 0.024 | 0.063 | Leukotriene C antagonist | 0.061 0.028 DBMET00536 | ||
| 0.149 | 0.11 | 0.149 | Hepatoprotectant | |||
| 0.068 | 0.031 | 0.068 | Cathepsin E inhibitor | |||
| 0.088 | 0.05 | 0.088 | Histamine H2 receptor antagonist | |||
| 0.076 | 0.039 | 0.076 | Selectin antagonist | |||
| 0.061 | 0.024 | 0.061 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.109 | 0.075 | 0.176 | Microtubule formation inhibitor | 0.176 0.027 DBMET00536 | DBMET00536 | |
| 0.065 | 0.031 | 0.07 | Sphingosine kinase inhibitor | 0.07 0.025 DBMET00536 | DBMET00536 | |
| 0.14 | 0.106 | 0.14 | Nitric oxide antagonist | |||
| 0.098 | 0.066 | 0.149 | Anabolic | 0.149 0.018 DBMET00536 | DBMET00536 | |
| 0.041 | 0.009 | 0.041 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.068 | 0.04 | 0.07 | Protease 3C (Human rhinovirus) inhibitor | 0.07 0.036 DBMET00536 | DBMET00536 | |
| 0.055 | 0.028 | 0.055 | Bombesin 2 receptor antagonist | 0.053 0.03 DBMET00536 | ||
| 0.127 | 0.1 | 0.127 | Hemostatic | 0.125 0.104 DBMET00536 | ||
| 0.106 | 0.079 | 0.106 | Cell adhesion inhibitor | |||
| 0.101 | 0.075 | 0.245 | Monophenol monooxygenase inhibitor | 0.245 0.025 DBMET00536 | DBMET00536 | |
| 0.053 | 0.027 | 0.07 | Adenosine deaminase inhibitor | 0.07 0.013 DBMET00536 | DBMET00536 | |
| 0.086 | 0.061 | 0.086 | Interleukin 5 antagonist | |||
| 0.048 | 0.024 | 0.048 | HIV-1 protease inhibitor | |||
| 0.038 | 0.014 | 0.043 | Lysophosphatidic acid 2 receptor antagonist | 0.043 0.011 DBMET00536 | DBMET00536 | |
| 0.126 | 0.103 | 0.13 | Thiol protease inhibitor | 0.13 0.096 DBMET00536 | DBMET00536 | |
| 0.188 | 0.167 | 0.214 | Hypoxia-inducible factor 1 alpha inhibitor | 0.214 0.135 DBMET00536 | DBMET00536 | |
| 0.099 | 0.078 | 0.099 | Chelator | |||
| 0.15 | 0.13 | 0.15 | Anticonvulsant | |||
| 0.055 | 0.037 | 0.072 | Immunoglobulin Fc receptor antagonist | 0.072 0.01 DBMET00536 | DBMET00536 | |
| 0.063 | 0.045 | 0.091 | Calcium channel P-type blocker | 0.091 0.008 DBMET00536 | DBMET00536 | |
| 0.056 | 0.038 | 0.056 | Human rhinovirus A protease inhibitor | |||
| 0.112 | 0.095 | 0.119 | Antibacterial (Helicobacter pylori) | 0.119 0.083 DBMET00536 | DBMET00536 | |
| 0.028 | 0.012 | 0.028 | Prostaglandin E2 agonist | |||
| 0.036 | 0.02 | 0.036 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.036 | 0.021 | 0.036 | HMG CoA reductase inhibitor | |||
| 0.054 | 0.039 | 0.081 | Sphingosine kinase 2 inhibitor | 0.081 0.014 DBMET00536 | DBMET00536 | |
| 0.097 | 0.082 | 0.209 | DOPA decarboxylase inhibitor | 0.209 0.005 DBMET00536 | DBMET00536 | |
| 0.208 | 0.193 | 0.208 | Toll-Like receptor agonist | |||
| 0.043 | 0.028 | 0.054 | Toll-Like receptor 2 agonist | 0.054 0.022 DBMET00536 | DBMET00536 | |
| 0.141 | 0.126 | 0.204 | Neurotensin receptor agonist | 0.204 0.033 DBMET00536 | DBMET00536 | |
| 0.054 | 0.039 | 0.054 | Myc inhibitor | |||
| 0.035 | 0.02 | 0.035 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.07 | 0.056 | 0.218 | Glutamate dehydrogenase inhibitor | 0.218 0.009 DBMET00536 | DBMET00536 | |
| 0.023 | 0.01 | 0.029 | Neuraminidase (Influenza B) inhibitor | 0.029 0.005 DBMET00536 | DBMET00536 | |
| 0.052 | 0.039 | 0.113 | Alpha-mannosidase inhibitor | 0.113 0.005 DBMET00536 | DBMET00536 | |
| 0.053 | 0.04 | 0.054 | Thromboxane synthase inhibitor | 0.054 0.038 DBMET00536 | DBMET00536 | |
| 0.081 | 0.068 | 0.081 | Transcription factor NF kappa B stimulant | |||
| 0.039 | 0.027 | 0.039 | Leukotriene C4 antagonist | 0.039 0.026 DBMET00536 | ||
| 0.055 | 0.043 | 0.055 | Dopamine uptake inhibitor | |||
| 0.019 | 0.008 | 0.019 | Vitamin D receptor agonist | |||
| 0.044 | 0.033 | 0.101 | Mannosidase inhibitor | 0.101 0.005 DBMET00536 | DBMET00536 | |
| 0.051 | 0.04 | 0.051 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.028 | 0.017 | 0.028 | Prostaglandin EP4 antagonist | |||
| 0.02 | 0.01 | 0.02 | Estrogen-related receptor gamma agonist | 0.02 0.011 DBMET00536 | ||
| 0.091 | 0.08 | 0.159 | Falcipain 3 inhibitor | 0.159 0.032 DBMET00536 | DBMET00536 | |
| 0.073 | 0.063 | 0.073 | Cell adhesion molecule inhibitor | |||
| 0.114 | 0.105 | 0.114 | Neurotrophic factor | |||
| 0.062 | 0.053 | 0.062 | Leukotriene synthesis inhibitor | |||
| 0.016 | 0.007 | 0.036 | Lysophosphatidic acid receptor 3 agonist | 0.036 0.003 DBMET00536 | DBMET00536 | |
| 0.08 | 0.071 | 0.08 | Vanilloid agonist | |||
| 0.024 | 0.015 | 0.024 | Prostaglandin EP2 agonist | 0.019 0.018 DBMET00536 | ||
| 0.061 | 0.053 | 0.061 | Matrix metalloproteinase inhibitor | |||
| 0.05 | 0.042 | 0.05 | Ribonucleotide reductase inhibitor | |||
| 0.061 | 0.053 | 0.107 | Sphingosine 1-phosphate receptor 4 agonist | 0.107 0.022 DBMET00536 | DBMET00536 | |
| 0.191 | 0.183 | 0.191 | Caspase 3 stimulant | |||
| 0.12 | 0.112 | 0.12 | Anticoagulant | |||
| 0.04 | 0.032 | 0.045 | Sphingosine kinase 1 inhibitor | 0.045 0.022 DBMET00536 | DBMET00536 | |
| 0.045 | 0.039 | 0.045 | Metalloproteinase-3 inhibitor | |||
| 0.032 | 0.026 | 0.154 | Fumarate hydratase inhibitor | 0.154 0.004 DBMET00536 | DBMET00536 | |
| 0.067 | 0.061 | 0.129 | Carbonic anhydrase XIII inhibitor | 0.129 0.027 DBMET00536 | DBMET00536 | |
| 0.051 | 0.045 | 0.051 | Angiotensin-converting enzyme inhibitor | |||
| 0.033 | 0.028 | 0.033 | Renin inhibitor | |||
| 0.208 | 0.202 | 0.419 | Calcium channel activator | 0.419 0.018 DBMET00536 | DBMET00536 | |
| 0.06 | 0.055 | 0.06 | Neuraminidase (influenza) inhibitor | |||
| 0.042 | 0.038 | 0.042 | Neuraminidase (Influenza A) inhibitor | |||
| 0.056 | 0.051 | 0.056 | Glucagon-like peptide 1 agonist | |||
| 0.066 | 0.064 | 0.066 | Metalloproteinase-9 inhibitor | |||
| 0.021 | 0.019 | 0.021 | Aminopeptidase P inhibitor | |||
| 0.029 | 0.026 | 0.034 | Cholesterol ester transfer protein antagonist | 0.034 0.018 DBMET00536 | DBMET00536 | |
| 0.012 | 0.01 | 0.012 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.015 | 0.014 | 0.019 | Ileal bile acid transport inhibitor | 0.019 0.01 DBMET00536 | DBMET00536 | |
| 0.091 | 0.09 | 0.091 | Nav1.4 sodium channel blocker | |||
| 0.048 | 0.047 | 0.048 | Vanilloid 2 antagonist | |||
| 0.024 | 0.023 | 0.025 | Thyroid hormone agonist | 0.025 0.02 DBMET00536 | DBMET00536 | |
| 0.049 | 0.048 | 0.049 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.051 | 0.051 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.048 DBMET00536 | DBMET00536 | |
| 0.098 | 0.098 | 0.268 | Amylase inhibitor | 0.268 0.023 DBMET00536 | DBMET00536 | |
| 0.085 | 0.086 | 0.108 | Bile acid receptor antagonist | 0.108 0.033 DBMET00536 | DBMET00536 | |
| 0.062 | 0.066 | 0.21 | Glutamate decarboxylase inhibitor | 0.21 0.006 DBMET00536 | DBMET00536 | |
| 0.136 | 0.141 | 0.394 | Succinate dehydrogenase inhibitor | 0.394 0.004 DBMET00536 | DBMET00536 | |
| 0.018 | 0.023 | 0.022 | Lysophosphatidic acid 1 receptor antagonist | 0.022 0.013 DBMET00536 | DBMET00536 | |
| 0.101 | 0.106 | 0.166 | Cathepsin H inhibitor | 0.166 0.036 DBMET00536 | DBMET00536 | |
| 0.044 | 0.051 | 0.199 | Aconitate hydratase inhibitor | 0.199 0.003 DBMET00536 | DBMET00536 | |
| 0.019 | 0.027 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.028 0.007 DBMET00536 | DBMET00536 | |
| 0.037 | 0.045 | 0.045 | Antimetabolite | 0.045 0.035 DBMET00536 | DBMET00536 | |
| 0.064 | 0.073 | 0.14 | GABA aminotransferase inhibitor | 0.14 0.01 DBMET00536 | DBMET00536 | |
| 0.061 | 0.07 | 0.075 | Secretase beta inhibitor | 0.075 0.043 DBMET00536 | DBMET00536 | |
| 0.007 | 0.017 | 0.012 | Thromboxane agonist | 0.012 0.007 DBMET00536 | DBMET00536 | |
| 0.025 | 0.037 | 0.057 | Arginase inhibitor | 0.057 0.011 DBMET00536 | DBMET00536 | |
| 0.043 | 0.057 | 0.054 | CD45 antagonist | 0.054 0.028 DBMET00536 | DBMET00536 | |
| 0.004 | 0.018 | 0.009 | Mannitol 2-dehydrogenase inhibitor | 0.009 0.005 DBMET00536 | DBMET00536 | |
| 0.058 | 0.073 | 0.112 | Na+ K+ transporting ATPase inhibitor | 0.112 0.022 DBMET00536 | DBMET00536 | |
| 0.038 | 0.054 | 0.126 | Ornithine carbamoyltransferase inhibitor | 0.126 0.012 DBMET00536 | DBMET00536 | |
| 0.027 | 0.043 | 0.041 | Melatonin receptor 1A agonist | 0.041 0.013 DBMET00536 | DBMET00536 | |
| 0.11 | 0.126 | 0.167 | Sphingosine 1-phosphate receptor 2 antagonist | 0.167 0.024 DBMET00536 | DBMET00536 | |
| 0.109 | 0.126 | 0.122 | Acetylcholine M1 receptor antagonist | 0.122 0.106 DBMET00536 | DBMET00536 | |
| 0.045 | 0.064 | 0.084 | Carbonic anhydrase stimulant | 0.084 0.024 DBMET00536 | DBMET00536 | |
| 0.033 | 0.055 | 0.073 | Geranyltranstransferase inhibitor | 0.073 0.006 DBMET00536 | DBMET00536 | |
| 0.044 | 0.067 | 0.239 | Carbamoyl phosphate synthetase inhibitor | 0.239 0.006 DBMET00536 | DBMET00536 | |
| 0.014 | 0.038 | 0.027 | Antibiotic Anthracycline-like | 0.027 0.004 DBMET00536 | DBMET00536 | |
| 0.08 | 0.106 | 0.296 | Cystathionine beta-synthase inhibitor | 0.296 0.01 DBMET00536 | DBMET00536 | |
| 0.082 | 0.109 | 0.305 | Adenylate kinase inhibitor | 0.305 0.007 DBMET00536 | DBMET00536 | |
| 0.022 | 0.051 | 0.07 | Phosphoglycerate kinase inhibitor | 0.07 0.01 DBMET00536 | DBMET00536 | |
| 0.18 | 0.209 | 0.196 | Calpain 2 inhibitor | 0.196 0.191 DBMET00536 | DBMET00536 | |
| 0.02 | 0.05 | 0.031 | Calcitonin receptor agonist | 0.031 0.025 DBMET00536 | DBMET00536 | |
| 0.009 | 0.039 | 0.024 | Thromboxane A2 agonist | 0.024 0.004 DBMET00536 | DBMET00536 | |
| 0.008 | 0.04 | 0.016 | Aminopeptidase A inhibitor | 0.016 0.014 DBMET00536 | DBMET00536 | |
| 0.008 | 0.04 | 0.045 | Carbonic anhydrase VIII inhibitor | 0.045 0.003 DBMET00536 | DBMET00536 | |
| 0.008 | 0.04 | 0.045 | Carbonic anhydrase X inhibitor | 0.045 0.003 DBMET00536 | DBMET00536 | |
| 0.02 | 0.054 | 0.037 | Methionyl aminopeptidase 1 inhibitor | 0.037 0.015 DBMET00536 | DBMET00536 | |
| 0.024 | 0.058 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.023 DBMET00536 | DBMET00536 | |
| 0.068 | 0.104 | 0.331 | Triose-phosphate isomerase inhibitor | 0.331 0.004 DBMET00536 | DBMET00536 | |
| 0.069 | 0.106 | 0.316 | NADH dehydrogenase inhibitor | 0.316 0.006 DBMET00536 | DBMET00536 | |
| 0.042 | 0.082 | 0.24 | Phosphofructokinase-1 inhibitor | 0.24 0.008 DBMET00536 | DBMET00536 | |
| 0.017 | 0.057 | 0.025 | Calcium-sensing receptor agonist | 0.025 0.021 DBMET00536 | DBMET00536 | |
| 0.014 | 0.055 | 0.038 | Lysine carboxypeptidase inhibitor | 0.038 0.011 DBMET00536 | DBMET00536 | |
| 0.111 | 0.153 | 0.18 | Sphingosine 1-phosphate receptor 5 antagonist | 0.18 0.023 DBMET00536 | DBMET00536 | |
| 0.161 | 0.204 | 0.213 | Neuropeptide Y2 antagonist | 0.213 0.099 DBMET00536 | DBMET00536 | |
| 0.123 | 0.167 | 0.171 | Heat shock protein 70 antagonist | 0.171 0.017 DBMET00536 | DBMET00536 | |
| 0.044 | 0.088 | 0.113 | NMDA receptor agonist | 0.113 0.015 DBMET00536 | DBMET00536 | |
| 0.03 | 0.074 | 0.055 | Carbonic anhydrase XIV inhibitor | 0.055 0.028 DBMET00536 | DBMET00536 | |
| 0.005 | 0.05 | 0.016 | G-protein-coupled receptor 120 agonist | 0.016 0.013 DBMET00536 | DBMET00536 | |
| 0.05 | 0.096 | 0.094 | Epoxide hydrolase inhibitor | 0.094 0.029 DBMET00536 | DBMET00536 | |
| 0.009 | 0.055 | 0.029 | Prostaglandin H2 antagonist | 0.029 0.014 DBMET00536 | DBMET00536 | |
| 0.033 | 0.08 | 0.911 | Alcohol oxidase inhibitor | 0.911 0.002 DBMET00536 | DBMET00536 | |
| 0.036 | 0.084 | 0.059 | Cytokine production stimulant | 0.059 0.013 DBMET00536 | DBMET00536 | |
| 0.057 | 0.106 | 0.135 | Carbonic anhydrase VI inhibitor | 0.135 0.024 DBMET00536 | DBMET00536 | |
| 0.024 | 0.074 | 0.062 | Membrane dipeptidase inhibitor | 0.062 0.009 DBMET00536 | DBMET00536 | |
| 0.044 | 0.094 | 0.057 | Adenine nucleotide translocase inhibitor | 0.057 0.035 DBMET00536 | DBMET00536 | |
| 0.152 | 0.204 | 0.219 | 12-Lipoxygenase inhibitor | 0.219 0.132 DBMET00536 | DBMET00536 | |
| 0.033 | 0.085 | 0.128 | Glucose-6-phosphate isomerase inhibitor | 0.128 0.003 DBMET00536 | DBMET00536 | |
| 0.054 | 0.106 | 0.16 | Glycine receptor agonist | 0.16 0.006 DBMET00536 | DBMET00536 | |
| 0.082 | 0.138 | 0.138 | Acetylcholine release stimulant | 0.138 0.025 DBMET00536 | DBMET00536 | |
| 0.073 | 0.129 | 0.208 | Carbonic anhydrase XV inhibitor | 0.208 0.017 DBMET00536 | DBMET00536 | |
| 0.016 | 0.074 | 0.046 | Free fatty acid receptor 1 antagonist | 0.046 0.011 DBMET00536 | DBMET00536 | |
| 0.034 | 0.093 | 0.227 | Biliverdin reductase inhibitor | 0.227 0.005 DBMET00536 | DBMET00536 | |
| 0.034 | 0.094 | 0.061 | 5 Hydroxytryptamine 2A agonist | 0.061 0.046 DBMET00536 | DBMET00536 | |
| 0.012 | 0.074 | 0.023 | Methylmalonyl-CoA mutase inhibitor | 0.023 0.005 DBMET00536 | DBMET00536 | |
| 0.029 | 0.091 | 0.199 | Acyl-CoA dehydrogenase inhibitor | 0.199 0.005 DBMET00536 | DBMET00536 | |
| 0.015 | 0.079 | 0.037 | Vanilloid 2 agonist | 0.037 0.005 DBMET00536 | DBMET00536 | |
| 0.05 | 0.116 | 0.131 | Glutamate (mGluR6) antagonist | 0.131 0.004 DBMET00536 | DBMET00536 | |
| 0.058 | 0.125 | 0.126 | GABA B receptor agonist | 0.126 0.006 DBMET00536 | DBMET00536 | |
| 0.013 | 0.081 | 0.056 | Retinoid X receptor agonist | 0.056 0.015 DBMET00536 | DBMET00536 | |
| 0.015 | 0.085 | 0.025 | Acid ceramidase inhibitor | 0.025 0.019 DBMET00536 | DBMET00536 | |
| 0.033 | 0.105 | 0.066 | Squalene epoxidase inhibitor | 0.066 0.016 DBMET00536 | DBMET00536 | |
| 0.066 | 0.139 | 0.119 | MAP kinase kinase 1 inhibitor | 0.119 0.036 DBMET00536 | DBMET00536 | |
| 0.026 | 0.1 | 0.062 | AICAR transformylase inhibitor | 0.062 0.013 DBMET00536 | DBMET00536 | |
| 0.016 | 0.091 | 0.035 | Carnitine palmitoyltransferase inhibitor | 0.035 0.022 DBMET00536 | DBMET00536 | |
| 0.014 | 0.09 | 0.021 | ICAM 1 antagonist | 0.021 0.02 DBMET00536 | DBMET00536 | |
| 0.006 | 0.084 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.013 DBMET00536 | DBMET00536 | |
| 0.083 | 0.162 | 0.562 | Peroxidase inhibitor | 0.562 0.005 DBMET00536 | DBMET00536 | |
| 0.071 | 0.15 | 0.104 | Phosphodiesterase 6D inhibitor | 0.104 0.045 DBMET00536 | DBMET00536 | |
| 0.018 | 0.097 | 0.055 | Oxytocin agonist | 0.055 0.021 DBMET00536 | DBMET00536 | |
| 0.019 | 0.099 | 0.065 | Glutamate (mGluR3) antagonist | 0.065 0.007 DBMET00536 | DBMET00536 | |
| 0.011 | 0.092 | 0.034 | Liver X receptor beta antagonist | 0.034 0.016 DBMET00536 | DBMET00536 | |
| 0.023 | 0.104 | 0.038 | Glutamate (mGluR8) antagonist | 0.038 0.02 DBMET00536 | DBMET00536 | |
| 0.017 | 0.098 | 0.06 | Dihydropteroate synthase inhibitor | 0.06 0.011 DBMET00536 | DBMET00536 | |
| 0.022 | 0.103 | 0.041 | Liver X receptor alpha agonist | 0.041 0.029 DBMET00536 | DBMET00536 | |
| 0.116 | 0.199 | 0.256 | Neurotrophic factor enhancer | 0.256 0.035 DBMET00536 | DBMET00536 | |
| 0.064 | 0.147 | 0.255 | GABA C receptor rho-1 antagonist | 0.255 0.004 DBMET00536 | DBMET00536 | |
| 0.038 | 0.122 | 0.067 | Heat shock protein 90 beta antagonist | 0.067 0.031 DBMET00536 | DBMET00536 | |
| 0.02 | 0.104 | 0.051 | Glutamate (mGluR3) agonist | 0.051 0.005 DBMET00536 | DBMET00536 | |
| 0.012 | 0.097 | 0.019 | Toll-Like receptor 8 agonist | 0.019 0.017 DBMET00536 | DBMET00536 | |
| 0.019 | 0.106 | 0.07 | GABA uptake inhibitor | 0.07 0.007 DBMET00536 | DBMET00536 | |
| 0.063 | 0.153 | 0.202 | Electrolyte absorption antagonist | 0.202 0.008 DBMET00536 | DBMET00536 | |
| 0.019 | 0.11 | 0.051 | Potassium channel Kv1.3 blocker | 0.051 0.028 DBMET00536 | DBMET00536 | |
| 0.013 | 0.104 | 0.046 | Diamine oxidase inhibitor | 0.046 0.017 DBMET00536 | DBMET00536 | |
| 0.015 | 0.106 | 0.036 | Carnitine palmitoyltransferase 1 inhibitor | 0.036 0.021 DBMET00536 | DBMET00536 | |
| 0.023 | 0.114 | 0.06 | Dihydroorotase inhibitor | 0.06 0.016 DBMET00536 | DBMET00536 | |
| 0.057 | 0.15 | 0.347 | UDP-glucose 4-epimerase inhibitor | 0.347 0.008 DBMET00536 | DBMET00536 | |
| 0.007 | 0.1 | 0.019 | Purinergic P2Y1 agonist | 0.019 0.007 DBMET00536 | DBMET00536 | |
| 0.036 | 0.129 | 0.138 | Purinergic P2X1 antagonist | 0.138 0.009 DBMET00536 | DBMET00536 | |
| 0.044 | 0.146 | 0.08 | Potassium channel (Tandem pore domain) blocker | 0.08 0.034 DBMET00536 | DBMET00536 | |
| 0.043 | 0.146 | 0.103 | Macrophage migration inhibitory factor inhibitor | 0.103 0.033 DBMET00536 | DBMET00536 | |
| 0.017 | 0.12 | 0.043 | Hedgehog signaling activator | 0.043 0.004 DBMET00536 | DBMET00536 | |
| 0.024 | 0.128 | 0.188 | Argininosuccinate synthase inhibitor | 0.188 0.008 DBMET00536 | DBMET00536 | |
| 0.041 | 0.148 | 0.089 | Ryanodine receptor antagonist | 0.089 0.005 DBMET00536 | DBMET00536 | |
| 0.024 | 0.131 | 0.045 | Prolyl endopeptidase inhibitor | 0.045 0.044 DBMET00536 | DBMET00536 | |
| 0.016 | 0.123 | 0.089 | Carbonic anhydrase VB inhibitor | 0.089 0.019 DBMET00536 | DBMET00536 | |
| 0.025 | 0.134 | 0.081 | Kainate receptor agonist | 0.081 0.004 DBMET00536 | DBMET00536 | |
| 0.011 | 0.124 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 DBMET00536 | DBMET00536 | |
| 0.012 | 0.126 | 0.056 | Retinoid X alpha receptor agonist | 0.056 0.012 DBMET00536 | DBMET00536 | |
| 0.003 | 0.116 | 0.025 | Glutamate (mGluR6) agonist | 0.025 0.004 DBMET00536 | DBMET00536 | |
| 0.008 | 0.125 | 0.037 | Sodium/glucose cotransporter 2 inhibitor | 0.037 0.009 DBMET00536 | DBMET00536 | |
| 0.031 | 0.148 | 0.05 | Heme oxygenase inhibitor | 0.05 0.014 DBMET00536 | DBMET00536 | |
| 0.021 | 0.139 | 0.088 | Glutamate (mGluR8) agonist | 0.088 0.004 DBMET00536 | DBMET00536 | |
| 0.05 | 0.169 | 0.097 | Vanilloid 4 agonist | 0.097 0.019 DBMET00536 | DBMET00536 | |
| 0.007 | 0.128 | 0.042 | Kynurenine 3 monooxygenase inhibitor | 0.042 0.009 DBMET00536 | DBMET00536 | |
| 0.017 | 0.137 | 0.043 | Ceramide glucosyltransferase inhibitor | 0.043 0.014 DBMET00536 | DBMET00536 | |
| 0.011 | 0.139 | 0.039 | Farnesoid X receptor agonist | 0.039 0.024 DBMET00536 | DBMET00536 | |
| 0.005 | 0.133 | 0.05 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.05 0.009 DBMET00536 | DBMET00536 | |
| 0.047 | 0.176 | 0.171 | Prolactin inhibitor | 0.171 0.015 DBMET00536 | DBMET00536 | |
| 0.096 | 0.225 | 0.181 | Non-steroidal antiinflammatory agent | 0.181 0.086 DBMET00536 | DBMET00536 | |
| 0.023 | 0.154 | 0.049 | Carnitine palmitoyltransferase 1B inhibitor | 0.049 0.031 DBMET00536 | DBMET00536 | |
| 0.054 | 0.187 | 0.137 | Lanosterol 14 alpha demethylase inhibitor | 0.137 0.017 DBMET00536 | DBMET00536 | |
| 0.118 | 0.254 | 0.313 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.313 0.02 DBMET00536 | DBMET00536 | |
| 0.007 | 0.142 | 0.059 | Uridine phosphorylase inhibitor | 0.059 0.006 DBMET00536 | DBMET00536 | |
| 0.049 | 0.185 | 0.576 | GABA C receptor agonist | 0.576 0.003 DBMET00536 | DBMET00536 | |
| 0.018 | 0.154 | 0.047 | Tryptophan 5 hydroxylase inhibitor | 0.047 0.007 DBMET00536 | DBMET00536 | |
| 0.029 | 0.168 | 0.062 | Nicotinic alpha3beta2 receptor antagonist | 0.062 0.024 DBMET00536 | DBMET00536 | |
| 0.014 | 0.153 | 0.041 | Estrogen-related receptor gamma antagonist | 0.041 0.005 DBMET00536 | DBMET00536 | |
| 0.012 | 0.151 | 0.04 | ATP citrate lysase inhibitor | 0.04 0.013 DBMET00536 | DBMET00536 | |
| 0.023 | 0.164 | 0.047 | GABA B receptor antagonist | 0.047 0.023 DBMET00536 | DBMET00536 | |
| 0.003 | 0.144 | 0.014 | Adenosine A2a receptor agonist | 0.014 0.012 DBMET00536 | DBMET00536 | |
| 0.024 | 0.165 | 0.059 | Glutamate (mGluR4) antagonist | 0.059 0.014 DBMET00536 | DBMET00536 | |
| 0.02 | 0.162 | 0.111 | NMDA receptor glycine site agonist | 0.111 0.012 DBMET00536 | DBMET00536 | |
| 0.045 | 0.189 | 0.239 | Creatine kinase inhibitor | 0.239 0.006 DBMET00536 | DBMET00536 | |
| 0.031 | 0.175 | 0.102 | Phospholipase D inhibitor | 0.102 0.013 DBMET00536 | DBMET00536 | |
| 0.006 | 0.15 | 0.031 | Methionyl aminopeptidase 2 inhibitor | 0.031 0.013 DBMET00536 | DBMET00536 | |
| 0.111 | 0.259 | 0.197 | Ca2+-transporting ATPase inhibitor | 0.197 0.004 DBMET00536 | DBMET00536 | |
| 0.011 | 0.16 | 0.031 | Peptide deformylase inhibitor | 0.031 0.02 DBMET00536 | DBMET00536 | |
| 0.06 | 0.211 | 0.138 | Glutamate (mGluR7) agonist | 0.138 0.017 DBMET00536 | DBMET00536 | |
| 0.063 | 0.214 | 0.143 | TRPA1 agonist | 0.143 0.036 DBMET00536 | DBMET00536 | |
| 0.03 | 0.184 | 0.048 | Factor III inhibitor | 0.048 0.041 DBMET00536 | DBMET00536 | |
| 0.024 | 0.18 | 0.092 | Carbonic anhydrase VA inhibitor | 0.092 0.029 DBMET00536 | DBMET00536 | |
| 0.017 | 0.173 | 0.044 | Dihydrofolate reductase inhibitor | 0.044 0.03 DBMET00536 | DBMET00536 | |
| 0.067 | 0.223 | 0.125 | Interleukin 8 antagonist | 0.125 0.055 DBMET00536 | DBMET00536 | |
| 0.052 | 0.21 | 0.108 | AMP-activated protein kinase stimulant | 0.108 0.061 DBMET00536 | DBMET00536 | |
| 0.05 | 0.21 | 0.295 | GABA C receptor antagonist | 0.295 0.004 DBMET00536 | DBMET00536 | |
| 0.003 | 0.166 | 0.018 | Carbonic anhydrase XI inhibitor | 0.018 0.005 DBMET00536 | DBMET00536 | |
| 0.121 | 0.286 | 0.361 | RNA-directed DNA polymerase inhibitor | 0.361 0.023 DBMET00536 | DBMET00536 | |
| 0.021 | 0.187 | 0.092 | Carbonic anhydrase V inhibitor | 0.092 0.03 DBMET00536 | DBMET00536 | |
| 0.021 | 0.188 | 0.088 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.088 0.003 DBMET00536 | DBMET00536 | |
| 0.094 | 0.26 | 0.157 | Lipocortins synthesis antagonist | 0.157 0.095 DBMET00536 | DBMET00536 | |
| 0.044 | 0.212 | 0.408 | Ferrochelatase inhibitor | 0.408 0.004 DBMET00536 | DBMET00536 | |
| 0.031 | 0.2 | 0.07 | DNA helicase inhibitor | 0.07 0.017 DBMET00536 | DBMET00536 | |
| 0.026 | 0.194 | 0.059 | Botulinum neurotoxin type A inhibitor | 0.059 0.039 DBMET00536 | DBMET00536 | |
| 0.042 | 0.212 | 0.092 | Caspase 7 inhibitor | 0.092 0.038 DBMET00536 | DBMET00536 | |
| 0.005 | 0.175 | 0.027 | Telomerase stimulant | 0.027 0.004 DBMET00536 | DBMET00536 | |
| 0.024 | 0.195 | 0.334 | Porphobilinogen synthase inhibitor | 0.334 0.005 DBMET00536 | DBMET00536 | |
| 0.017 | 0.189 | 0.051 | Retinoid X receptor antagonist | 0.051 0.012 DBMET00536 | DBMET00536 | |
| 0.023 | 0.196 | 0.063 | Glutamate (mGluR group III) antagonist | 0.063 0.012 DBMET00536 | DBMET00536 | |
| 0.025 | 0.198 | 0.065 | Heparanase inhibitor | 0.065 0.017 DBMET00536 | DBMET00536 | |
| 0.003 | 0.183 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.01 DBMET00536 | DBMET00536 | |
| 0.016 | 0.198 | 0.044 | Retinoid X alpha receptor antagonist | 0.044 0.01 DBMET00536 | DBMET00536 | |
| 0.008 | 0.193 | 0.027 | Retinoid X beta receptor antagonist | 0.027 0.005 DBMET00536 | DBMET00536 | |
| 0.027 | 0.216 | 0.066 | Potassium channel (ATP-sensitive) blocker | 0.066 0.047 DBMET00536 | DBMET00536 | |
| 0.045 | 0.234 | 0.082 | MDM2 inhibitor | 0.082 0.018 DBMET00536 | DBMET00536 | |
| 0.011 | 0.204 | 0.08 | Dopamine D5 agonist | 0.08 0.006 DBMET00536 | DBMET00536 | |
| 0.037 | 0.229 | 0.072 | Phosphodiesterase VI inhibitor | 0.072 0.056 DBMET00536 | DBMET00536 | |
| 0.048 | 0.242 | 0.127 | Beta amyloid protein antagonist | 0.127 0.06 DBMET00536 | DBMET00536 | |
| 0.011 | 0.21 | 0.054 | Fructose-1,6-bisphosphatase inhibitor | 0.054 0.022 DBMET00536 | DBMET00536 | |
| 0.017 | 0.219 | 0.086 | Adenylate cyclase 1 inhibitor | 0.086 0.006 DBMET00536 | DBMET00536 | |
| 0.005 | 0.207 | 0.026 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.026 0.012 DBMET00536 | DBMET00536 | |
| 0.078 | 0.283 | 0.159 | Tumour necrosis factor antagonist | 0.159 0.089 DBMET00536 | DBMET00536 | |
| 0.027 | 0.234 | 0.075 | Glucosylceramidase inhibitor | 0.075 0.019 DBMET00536 | DBMET00536 | |
| 0.01 | 0.22 | 0.031 | Glutamate (mGluR1) agonist | 0.031 0.009 DBMET00536 | DBMET00536 | |
| 0.018 | 0.233 | 0.177 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.177 0.007 DBMET00536 | DBMET00536 | |
| 0.071 | 0.287 | 0.293 | GABA C receptor rho-2 antagonist | 0.293 0.006 DBMET00536 | DBMET00536 | |
| 0.128 | 0.347 | 0.232 | 5 Hydroxytryptamine 3E antagonist | 0.232 0.026 DBMET00536 | DBMET00536 | |
| 0.009 | 0.229 | 0.033 | Epoxide hydrolase 1 inhibitor | 0.033 0.017 DBMET00536 | DBMET00536 | |
| 0.071 | 0.292 | 0.144 | DNA repair enzyme inhibitor | 0.144 0.037 DBMET00536 | DBMET00536 | |
| 0.005 | 0.228 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.032 0.022 DBMET00536 | DBMET00536 | |
| 0.023 | 0.248 | 0.121 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.121 0.029 DBMET00536 | DBMET00536 | |
| 0.01 | 0.238 | 0.033 | Angiotensin II receptor antagonist | 0.033 0.026 DBMET00536 | DBMET00536 | |
| 0.02 | 0.25 | 0.069 | Dopamine beta hydroxylase inhibitor | 0.069 0.009 DBMET00536 | DBMET00536 | |
| 0.028 | 0.259 | 0.116 | Histamine N-methyltransferase inhibitor | 0.116 0.033 DBMET00536 | DBMET00536 | |
| 0.04 | 0.271 | 0.22 | Xanthine oxidase inhibitor | 0.22 0.016 DBMET00536 | DBMET00536 | |
| 0.009 | 0.245 | 0.045 | Angiotensin AT1 receptor antagonist | 0.045 0.025 DBMET00536 | DBMET00536 | |
| 0.018 | 0.255 | 0.051 | HCV NS3/NS4A protease inhibitor | 0.051 0.031 DBMET00536 | DBMET00536 | |
| 0.019 | 0.257 | 0.053 | Vanilloid 3 antagonist | 0.053 0.007 DBMET00536 | DBMET00536 | |
| 0.008 | 0.248 | 0.043 | Nicotinic acid receptor agonist | 0.043 0.018 DBMET00536 | DBMET00536 | |
| 0.018 | 0.258 | 0.076 | Androgen agonist | 0.076 0.026 DBMET00536 | DBMET00536 | |
| 0.026 | 0.269 | 0.111 | Potassium channel (Ca-activated) activator | 0.111 0.047 DBMET00536 | DBMET00536 | |
| 0.037 | 0.282 | 0.075 | Estrogen receptor alpha antagonist | 0.075 0.058 DBMET00536 | DBMET00536 | |
| 0.042 | 0.29 | 0.17 | Cytidine deaminase inhibitor | 0.17 0.062 DBMET00536 | DBMET00536 | |
| 0.034 | 0.284 | 0.196 | HIV-1 integrase (Overall Integration) inhibitor | 0.196 0.012 DBMET00536 | DBMET00536 | |
| 0.006 | 0.259 | 0.041 | Nicotinic acid receptor 2 antagonist | 0.041 0.005 DBMET00536 | DBMET00536 | |
| 0.017 | 0.275 | 0.036 | Adenosine uptake inhibitor | 0.036 0.021 DBMET00536 | DBMET00536 | |
| 0.029 | 0.291 | 0.119 | Urease inhibitor | 0.119 0.045 DBMET00536 | DBMET00536 | |
| 0.006 | 0.27 | 0.035 | NMDA receptor subunit 3A antagonist | 0.035 0.03 DBMET00536 | DBMET00536 | |
| 0.108 | 0.379 | 0.231 | Antibacterial | 0.231 0.195 DBMET00536 | DBMET00536 | |
| 0.002 | 0.273 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 DBMET00536 | DBMET00536 | |
| 0.007 | 0.279 | 0.075 | Guanylate cyclase inhibitor | 0.075 0.004 DBMET00536 | DBMET00536 | |
| 0.005 | 0.287 | 0.044 | Kainate receptor 2 antagonist | 0.044 0.019 DBMET00536 | DBMET00536 | |
| 0.011 | 0.297 | 0.049 | Histamine H2 receptor agonist | 0.049 0.022 DBMET00536 | DBMET00536 | |
| 0.023 | 0.311 | 0.124 | Glutamate (mGluR7) antagonist | 0.124 0.004 DBMET00536 | DBMET00536 | |
| 0.017 | 0.305 | 0.082 | Androgen antagonist | 0.082 0.064 DBMET00536 | DBMET00536 | |
| 0.029 | 0.318 | 0.09 | Nitric-oxide synthase inhibitor | 0.09 0.077 DBMET00536 | DBMET00536 | |
| 0.012 | 0.303 | 0.067 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.067 0.033 DBMET00536 | DBMET00536 | |
| 0.022 | 0.313 | 0.086 | Pregnane X receptor antagonist | 0.086 0.005 DBMET00536 | DBMET00536 | |
| 0.046 | 0.338 | 0.198 | Cell wall synthesis inhibitor | 0.198 0.031 DBMET00536 | DBMET00536 | |
| 0.007 | 0.301 | 0.047 | Purinergic P2Y15 antagonist | 0.047 0.004 DBMET00536 | DBMET00536 | |
| 0.027 | 0.334 | 0.098 | MAP kinase kinase inhibitor | 0.098 0.097 DBMET00536 | DBMET00536 | |
| 0.011 | 0.321 | 0.045 | Integrin alpha2 antagonist | 0.045 0.015 DBMET00536 | DBMET00536 | |
| 0.026 | 0.343 | 0.068 | Adenosine A3 receptor antagonist | 0.068 0.062 DBMET00536 | DBMET00536 | |
| 0.008 | 0.327 | 0.031 | Integrin alpha2beta1 antagonist | 0.031 0.011 DBMET00536 | DBMET00536 | |
| 0.015 | 0.339 | 0.092 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.092 0.012 DBMET00536 | DBMET00536 | |
| 0.007 | 0.335 | 0.045 | NMDA receptor subunit 3B antagonist | 0.045 0.029 DBMET00536 | DBMET00536 | |
| 0.003 | 0.336 | 0.024 | Nicotinic acid receptor 1 antagonist | 0.024 0.005 DBMET00536 | DBMET00536 | |
| 0.009 | 0.344 | 0.128 | Xanthine dehydrogenase inhibitor | 0.128 0.01 DBMET00536 | DBMET00536 | |
| 0.006 | 0.343 | 0.034 | Inosine monophosphate dehydrogenase inhibitor | 0.034 0.029 DBMET00536 | DBMET00536 | |
| 0.023 | 0.363 | 0.098 | Myeloperoxidase inhibitor | 0.098 0.038 DBMET00536 | DBMET00536 | |
| 0.002 | 0.35 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 DBMET00536 | DBMET00536 | |
| 0.016 | 0.365 | 0.053 | Aldosterone antagonist | 0.053 0.025 DBMET00536 | DBMET00536 | |
| 0.013 | 0.367 | 0.053 | Thymidine kinase inhibitor | 0.053 0.017 DBMET00536 | DBMET00536 | |
| 0.007 | 0.365 | 0.053 | Thymidylate synthase inhibitor | 0.053 0.024 DBMET00536 | DBMET00536 | |
| 0.007 | 0.365 | 0.064 | NMDA 2C receptor antagonist | 0.064 0.04 DBMET00536 | DBMET00536 | |
| 0.004 | 0.37 | 0.02 | Protease (Human cytomegalovirus) inhibitor | 0.02 0.019 DBMET00536 | DBMET00536 | |
| 0.005 | 0.371 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.025 0.008 DBMET00536 | DBMET00536 | |
| 0.009 | 0.376 | 0.054 | Acetylcholine M5 receptor antagonist | 0.054 0.052 DBMET00536 | DBMET00536 | |
| 0.031 | 0.4 | 0.102 | MAP kinase kinase 7 inhibitor | 0.102 0.011 DBMET00536 | DBMET00536 | |
| 0.01 | 0.382 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.031 0.01 DBMET00536 | DBMET00536 | |
| 0.025 | 0.398 | 0.101 | Exportin-1 inhibitor | 0.101 0.009 DBMET00536 | DBMET00536 | |
| 0.004 | 0.381 | 0.038 | Kainate receptor antagonist | 0.038 0.031 DBMET00536 | DBMET00536 | |
| 0.022 | 0.403 | 0.117 | Protein kinase C gamma inhibitor | 0.117 0.055 DBMET00536 | DBMET00536 | |
| 0.001 | 0.382 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET00536 | DBMET00536 | |
| 0.016 | 0.399 | 0.074 | Potassium channel intermediate-conductance Ca-activated blocker | 0.074 0.023 DBMET00536 | DBMET00536 | |
| 0.008 | 0.4 | 0.09 | Acetylcholine M5 receptor agonist | 0.09 0.026 DBMET00536 | DBMET00536 | |
| 0.003 | 0.395 | 0.048 | Glutamate (mGluR1a) agonist | 0.048 0.005 DBMET00536 | DBMET00536 | |
| 0.084 | 0.478 | 0.554 | GABA C receptor rho-3 antagonist | 0.554 0.014 DBMET00536 | DBMET00536 | |
| 0.017 | 0.411 | 0.131 | Glycine receptor antagonist | 0.131 0.013 DBMET00536 | DBMET00536 | |
| 0.013 | 0.413 | 0.083 | Inducible nitric-oxide synthase inhibitor | 0.083 0.057 DBMET00536 | DBMET00536 | |
| 0.052 | 0.457 | 0.204 | CF transmembrane conductance regulator agonist | 0.204 0.019 DBMET00536 | DBMET00536 | |
| 0.008 | 0.413 | 0.057 | Cyclin-dependent kinase 6 inhibitor | 0.057 0.045 DBMET00536 | DBMET00536 | |
| 0.036 | 0.442 | 0.129 | D-Ala-D-Ala ligase inhibitor | 0.129 0.01 DBMET00536 | DBMET00536 | |
| 0.026 | 0.437 | 0.193 | MAP kinase kinase 2 inhibitor | 0.193 0.086 DBMET00536 | DBMET00536 | |
| 0.009 | 0.426 | 0.081 | Nicotinic alpha4beta2 receptor antagonist | 0.081 0.049 DBMET00536 | DBMET00536 | |
| 0.009 | 0.427 | 0.046 | Potassium channel (Inward rectifier) blocker | 0.046 0.04 DBMET00536 | DBMET00536 | |
| 0.009 | 0.43 | 0.037 | 5 Hydroxytryptamine 2B agonist | 0.037 0.032 DBMET00536 | DBMET00536 | |
| 0.022 | 0.445 | 0.131 | Alkaline phosphatase inhibitor | 0.131 0.075 DBMET00536 | DBMET00536 | |
| 0.003 | 0.426 | 0.018 | Complement factor D inhibitor | 0.018 0.013 DBMET00536 | DBMET00536 | |
| 0.007 | 0.437 | 0.046 | Histamine H1 receptor agonist | 0.046 0.025 DBMET00536 | DBMET00536 | |
| 0.041 | 0.472 | 0.204 | Hexokinase inhibitor | 0.204 0.033 DBMET00536 | DBMET00536 | |
| 0.003 | 0.439 | 0.032 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.015 DBMET00536 | DBMET00536 | |
| 0.002 | 0.447 | 0.02 | Cyclin T1 inhibitor | 0.02 0.01 DBMET00536 | DBMET00536 | |
| 0.027 | 0.476 | 0.242 | Mannose-6-phosphate isomerase inhibitor | 0.242 0.014 DBMET00536 | DBMET00536 | |
| 0.012 | 0.469 | 0.037 | Potassium channel Kv1.1 blocker | 0.037 0.029 DBMET00536 | DBMET00536 | |
| 0.01 | 0.475 | 0.054 | Potassium channel (ATP-sensitive) activator | 0.054 0.023 DBMET00536 | DBMET00536 | |
| 0.01 | 0.477 | 0.057 | Potassium channel (Inward rectifier) activator | 0.057 0.023 DBMET00536 | DBMET00536 | |
| 0.003 | 0.47 | 0.037 | Estradiol 17 beta-dehydrogenase inhibitor | 0.037 0.034 DBMET00536 | DBMET00536 | |
| 0.04 | 0.511 | 0.095 | CC chemokine 5 receptor agonist | 0.095 0.028 DBMET00536 | DBMET00536 | |
| 0.011 | 0.484 | 0.102 | CYP2A6 inhibitor | 0.102 0.035 DBMET00536 | DBMET00536 | |
| 0.011 | 0.489 | 0.066 | Aryl hydrocarbon receptor antagonist | 0.066 0.043 DBMET00536 | DBMET00536 | |
| 0.041 | 0.52 | 0.157 | Focal adhesion kinase 2 inhibitor | 0.157 0.119 DBMET00536 | DBMET00536 | |
| 0.029 | 0.519 | 0.135 | NADPH oxidase inhibitor | 0.135 0.067 DBMET00536 | DBMET00536 | |
| 0.003 | 0.496 | 0.044 | Urate transporter 1 inhibitor | 0.044 0.022 DBMET00536 | DBMET00536 | |
| 0.019 | 0.518 | 0.191 | Pyruvate kinase inhibitor | 0.191 0.086 DBMET00536 | DBMET00536 | |
| 0.036 | 0.539 | 0.122 | Transcription factor STAT6 inhibitor | 0.122 0.056 DBMET00536 | DBMET00536 | |
| 0.007 | 0.512 | 0.042 | AMPA 4 receptor antagonist | 0.042 0.023 DBMET00536 | DBMET00536 | |
| 0.037 | 0.544 | 0.206 | 3C-like protease (Human coronavirus) inhibitor | 0.206 0.048 DBMET00536 | DBMET00536 | |
| 0 | 0.51 | 0.009 | Progesterone receptor A antagonist | 0.009 0.008 DBMET00536 | DBMET00536 | |
| 0.015 | 0.528 | 0.067 | Topoisomerase II beta inhibitor | 0.067 0.018 DBMET00536 | DBMET00536 | |
| 0.02 | 0.544 | 0.203 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.203 0.098 DBMET00536 | DBMET00536 | |
| 0.016 | 0.541 | 0.07 | Corticotropin releasing factor 2 receptor antagonist | 0.07 0.028 DBMET00536 | DBMET00536 | |
| 0.01 | 0.541 | 0.059 | Glutamate (mGluR group III) agonist | 0.059 0.019 DBMET00536 | DBMET00536 | |
| 0.009 | 0.542 | 0.055 | 5 Hydroxytryptamine 7 agonist | 0.055 0.042 DBMET00536 | DBMET00536 | |
| 0.027 | 0.563 | 0.244 | 5 Hydroxytryptamine 1E antagonist | 0.244 0.081 DBMET00536 | DBMET00536 | |
| 0.012 | 0.548 | 0.055 | CC chemokine 4 receptor antagonist | 0.055 0.021 DBMET00536 | DBMET00536 | |
| 0.001 | 0.545 | 0.013 | Egl nine homolog 3 inhibitor | 0.013 0.007 DBMET00536 | DBMET00536 | |
| 0.014 | 0.56 | 0.089 | Dihydroorotate oxidase inhibitor | 0.089 0.007 DBMET00536 | DBMET00536 | |
| 0.021 | 0.571 | 0.081 | Phosphodiesterase I inhibitor | 0.081 0.075 DBMET00536 | DBMET00536 | |
| 0.009 | 0.567 | 0.103 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.103 0.012 DBMET00536 | DBMET00536 | |
| 0.007 | 0.567 | 0.09 | Protein kinase C zeta inhibitor | 0.09 0.065 DBMET00536 | DBMET00536 | |
| 0.006 | 0.566 | 0.037 | Glutamate (mGluR4) agonist | 0.037 0.019 DBMET00536 | DBMET00536 | |
| 0 | 0.566 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.005 DBMET00536 | DBMET00536 | |
| 0.015 | 0.584 | 0.062 | Phosphodiesterase 1C inhibitor | 0.062 0.044 DBMET00536 | DBMET00536 | |
| 0.039 | 0.61 | 0.148 | MAP kinase 3 inhibitor | 0.148 0.07 DBMET00536 | DBMET00536 | |
| 0.008 | 0.588 | 0.072 | Protein kinase C beta inhibitor | 0.072 0.043 DBMET00536 | DBMET00536 | |
| 0.007 | 0.591 | 0.03 | Complement factor 1s inhibitor | 0.03 0.008 DBMET00536 | DBMET00536 | |
| 0.01 | 0.596 | 0.072 | Cyclin D1 inhibitor | 0.072 0.026 DBMET00536 | DBMET00536 | |
| 0.004 | 0.591 | 0.03 | Thymidine phosphorylase inhibitor | 0.03 0.012 DBMET00536 | DBMET00536 | |
| 0.03 | 0.618 | 0.179 | Histone acetyltransferase inhibitor | 0.179 0.102 DBMET00536 | DBMET00536 | |
| 0.019 | 0.623 | 0.116 | mTOR complex 2 inhibitor | 0.116 0.02 DBMET00536 | DBMET00536 | |
| 0.09 | 0.697 | 0.513 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.513 0.028 DBMET00536 | DBMET00536 | |
| 0.004 | 0.614 | 0.06 | Nerve growth factor antagonist | 0.06 0.009 DBMET00536 | DBMET00536 | |
| 0.008 | 0.635 | 0.043 | CF transmembrane conductance regulator antagonist | 0.043 0.019 DBMET00536 | DBMET00536 | |
| 0.013 | 0.64 | 0.119 | Beta glucuronidase inhibitor | 0.119 0.047 DBMET00536 | DBMET00536 | |
| 0.018 | 0.647 | 0.157 | Pregnane X receptor agonist | 0.157 0.041 DBMET00536 | DBMET00536 | |
| 0.021 | 0.657 | 0.078 | Transcription factor RelA inhibitor | 0.078 0.019 DBMET00536 | DBMET00536 | |
| 0.005 | 0.654 | 0.038 | Protein kinase (CK2) beta inhibitor | 0.038 0.015 DBMET00536 | DBMET00536 | |
| 0.001 | 0.667 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.012 DBMET00536 | DBMET00536 | |
| 0.002 | 0.706 | 0.075 | Alpha 1d adrenoreceptor agonist | 0.075 0.006 DBMET00536 | DBMET00536 | |
| 0.001 | 0.706 | 0.036 | Nicotinic alpha3beta4 receptor agonist | 0.036 0.013 DBMET00536 | DBMET00536 | |
| 0.011 | 0.724 | 0.1 | Bromodomain-containing protein 2 inhibitor | 0.1 0.04 DBMET00536 | DBMET00536 | |
| 0.009 | 0.726 | 0.204 | I kappa B kinase epsilon inhibitor | 0.204 0.068 DBMET00536 | DBMET00536 | |
| 0.006 | 0.729 | 0.188 | Aryl hydrocarbon receptor agonist | 0.188 0.109 DBMET00536 | DBMET00536 | |
| 0.008 | 0.755 | 0.073 | 5 Hydroxytryptamine 3 agonist | 0.073 0.033 DBMET00536 | DBMET00536 | |
| 0.008 | 0.758 | 0.168 | 5 Hydroxytryptamine 3A agonist | 0.168 0.026 DBMET00536 | DBMET00536 | |
| 0.004 | 0.766 | 0.04 | MAP3K5 inhibitor | 0.04 0.025 DBMET00536 | DBMET00536 | |
| 0.001 | 0.789 | 0.029 | Potassium channel small-conductance Ca-activated activator | 0.029 0.024 DBMET00536 | DBMET00536 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |